A detailed history of Ubs Group Ag transactions in Personalis, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,077 shares of PSNL stock, worth $24,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,077
Previous 87,959 91.95%
Holding current value
$24,557
Previous $102,000 62.75%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $6.34 $96,249 - $512,791
-80,882 Reduced 91.95%
7,077 $38,000
Q2 2024

Aug 13, 2024

BUY
$1.17 - $1.65 $89,795 - $126,634
76,748 Added 684.58%
87,959 $102,000
Q1 2024

May 13, 2024

BUY
$1.15 - $2.19 $1,128 - $2,148
981 Added 9.59%
11,211 $16,000
Q4 2023

Feb 09, 2024

SELL
$0.93 - $2.35 $9,653 - $24,393
-10,380 Reduced 50.36%
10,230 $21,000
Q3 2023

Nov 09, 2023

BUY
$1.19 - $2.36 $3,565 - $7,070
2,996 Added 17.01%
20,610 $24,000
Q2 2023

Aug 11, 2023

SELL
$1.8 - $3.19 $443,638 - $786,226
-246,466 Reduced 93.33%
17,614 $33,000
Q1 2023

May 12, 2023

BUY
$2.01 - $4.17 $5,668 - $11,759
2,820 Added 1.08%
264,080 $728,000
Q4 2022

Feb 08, 2023

BUY
$1.78 - $3.64 $178,838 - $365,714
100,471 Added 62.49%
261,260 $517,000
Q3 2022

Nov 10, 2022

BUY
$2.89 - $5.32 $16,799 - $30,925
5,813 Added 3.75%
160,789 $477,000
Q2 2022

Aug 10, 2022

BUY
$3.27 - $8.76 $453,702 - $1.22 Million
138,747 Added 854.93%
154,976 $535,000
Q1 2022

May 16, 2022

SELL
$7.56 - $14.3 $135,717 - $256,713
-17,952 Reduced 52.52%
16,229 $133,000
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $357,640 - $620,903
29,219 Added 588.86%
34,181 $487,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $3,571 - $5,574
-214 Reduced 4.13%
4,962 $95,000
Q2 2021

Aug 13, 2021

SELL
$18.15 - $27.75 $377,973 - $577,893
-20,825 Reduced 80.09%
5,176 $131,000
Q1 2021

May 12, 2021

BUY
$20.71 - $51.02 $390,984 - $963,206
18,879 Added 265.08%
26,001 $639,000
Q4 2020

Feb 11, 2021

BUY
$21.84 - $44.0 $13,235 - $26,664
606 Added 9.3%
7,122 $261,000
Q3 2020

Nov 12, 2020

SELL
$13.63 - $24.12 $115,309 - $204,055
-8,460 Reduced 56.49%
6,516 $141,000
Q2 2020

Jul 31, 2020

BUY
$7.65 - $14.11 $527 - $973
69 Added 0.46%
14,976 $194,000
Q1 2020

May 01, 2020

BUY
$4.75 - $12.41 $19,199 - $50,161
4,042 Added 37.2%
14,907 $120,000
Q4 2019

Feb 14, 2020

BUY
$8.73 - $12.95 $43,449 - $64,452
4,977 Added 84.53%
10,865 $118,000
Q3 2019

Nov 14, 2019

BUY
$14.16 - $25.34 $83,374 - $149,201
5,888 New
5,888 $86,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.